Using genomics to predict adverse drug reactions in children
Dr Hawcutt is a senior lecturer in paediatric pharmacology at the University of Liverpool, and honorary consultant in paediatrics at Alder Hey Children’s Hospital. He is the clinical lead on the NIHR Alder Hey Clinical Research Facility, undertaking early phase research into new medicines in children. Dr Hawcutt is also a member of the Medicines and Healthcare Regulatory Agency Pharmacovigilance Expert Advisory Committee on Pharmacovigilance, providing paediatric expertise. His research interests include pharmacogenomics of adverse drug reactions, early phase clinical trials, and pharmacovigilance.

This will be a great talk for anyone interested in pharmaceutics, paediatrics, or genomic medicine! There will be a q&a at the end – submissions for questions can be made via our instagram, facebook, or during the talk via a provided link.
Date: 2 November 2020, 17:00
Venue: https://us02web.zoom.us/meeting/register/tZ0vdO2qpz0uH9MK74e1FZI0RSBDEnxvU30W
Speaker: Dr Dan Hawcutt (University of Liverpool)
Organisers: Oxford Personalised Medicine Society (University of Oxford), Centre for Personalised Medicine
Organiser contact email address: oxmed@ox.ac.uk
Host: Oxford Personalised Medicine Society (University of Oxford)
Booking required?: Required
Booking url: https://us02web.zoom.us/meeting/register/tZ0vdO2qpz0uH9MK74e1FZI0RSBDEnxvU30W
Cost: free
Audience: Public
Editor: Holly Eggington